2023-04-06 | Sale | Prelude Therapeutics Incorporated PRLD | President, CMO | 13,280 0.0276% | $6.12 | $81,274 | -36.53% | |
2021-12-14 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $278.14 | $417,211 | -35.87% | |
2021-12-01 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,049 0.0011% | $359.86 | $377,493 | -49.27% | |
2021-11-17 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $381.34 | $572,003 | -52.73% | |
2021-10-19 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $372.78 | $559,163 | -50.91% | |
2021-09-20 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 6,000 0.0065% | $397.96 | $2.39M | -50.69% | |
2021-09-13 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 12,901 0.0137% | $358.14 | $4.62M | -45.11% | |
2021-09-02 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 545 0.0006% | $327.18 | $178,314 | -38.37% | |
2021-09-01 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 542 0.0006% | $310.53 | $168,307 | -37.16% | |
2021-07-15 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 21,000 0.0227% | $332.42 | $6.98M | -26.45% | |
2021-06-29 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $352.13 | $528,198 | -25.27% | |
2021-06-28 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 425 0.0005% | $365.00 | $155,125 | -24.88% | |
2021-06-18 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 469 0.0005% | $325.66 | $152,733 | -15.05% | |
2021-06-07 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 603 0.0007% | $351.55 | $211,986 | -19.12% | |
2021-06-01 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 540 0.0006% | $362.64 | $195,828 | -23.17% | |
2021-05-28 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $356.30 | $534,453 | -21.09% | |
2021-04-29 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $354.92 | $532,387 | -11.83% | |
2021-03-29 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $324.00 | $485,993 | -1.06% | |
2021-02-26 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0016% | $320.73 | $481,099 | +1.25% | |
2021-01-29 | Sale | BeiGene, Ltd. BGNE | CMO, Hematology | 1,500 0.0017% | $322.99 | $484,492 | +3.45% |